Acknowledgement to Referees

Dear Reader,

As we reach the final issue of Drug Safety for 2019, we wish to reflect on another successful year’s achievements, and to thank all those who have contributed their time and effort to guarantee the high quality of our content.

2019 was a successful year for Drug Safety. The quality of articles published in the journal is reflected in its most recent impact factor (3.526). Over 100 articles have been published this year; the most popular of these, in terms of downloads from SpringerLink as at October 2019, have been:

• Patient Registries: An Underused Resource for Medicines Evaluation: Operational proposals for increasing the use of patient registries in regulatory assessments Patricia McGettigan, Carla Alonso Olmo, Kelly Plueschke, Mireia Castillon, Daniel Nogueras Zondag, Priya Bahri, Xavier Kurz, Peter G. M. Mol

• Establishing a Framework for the Use of Social Media in Pharmacovigilance in Europe Sabine Brosch, Anne-Marie de Ferran, Victoria Newbould, Diane Farkas, Marina Lengsavath, Phil Tregunno

• Artificial Intelligence and the Future of the Drug Safety Professional Karolina Danysz, Salvatore Cicirello, Edward Mingle, Bruno Assuncao, Niki Tetarenko, Ruta Mockute, Danielle Abatemarco, Mark Widdowson, Sameen Desai

• Use of a Patient-Friendly Terms List in the Adverse Drug Reaction Report Form: A Database Study Sieta T. de Vries, Judy Harrison, Patrick Revelle, Alicia Ptaszynska-Neophytou, Anna Radecka, Gowthamei Ragunathan, Phil Tregunno, Petra Denig, Peter G. M. Mol

• Recommendations on the Use of Mobile Applications for the Collection and Communication of Pharmaceutical Product Safety Information: Lessons from IMI WEB-RADR Carrie E. Pierce, Sieta T. de Vries, Stephanie Bodin-Parssinen, Linda Härmark, Phil Tregunno, David J. Lewis, Simon Maskell, Raphael Van Eemeren, Alicia Ptaszynska-Neophytou, Victoria Newbould, Nabarun Dasgupta, Antoni F. Z. Wisniewski, Sara Gama, Peter G. M. Mol

• Ustekinumab Safety in Psoriasis, Psoriatic Arthritis, and Crohn’s Disease: An Integrated Analysis of Phase II/III Clinical Development Programs Subrata Ghosh, Lianne S. Gensler, Zijiang Yang, Chris Gasink, Soumya D. Chakravarty, Kamyar Farahi, Paraneedharan Ramachandran, Elyssa Ott, Bruce E. Strober

• Evaluation of the Reported Rates of Severe Hypersensitivity Reactions Associated with Ferric Carboxymaltose and Iron (III) Isomaltoside 1000 in Europe Based on Data from EudraVigilance and VigiBase™ between 2014 and 2017 Birgit Ehlken, Lennart Nathell, Annegret Gohlke, Derya Bocuk, Massoud Toussi, Stefan Wohlfeil

• Standardising the Classification of Harm Associated with Medication Errors: The Harm Associated with Medication Error Classification (HAMEC) Peter J. Gates, Melissa T. Baysari, Virginia Mumford, Magdalena Z. Raban, Johanna I. Westbrook

• Safety and Tolerability of Antibody-Drug Conjugates in Cancer Anna Wolska-Washer, Tadeusz Robak

• Benefit–Risk Assessment of Blinatumomab in the Treatment of Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia Anthony Stein, Janet L. Franklin, Victoria M. Chia, Deborah Arrindell, William Kormany, Jacqueline Wright, Mandy Parson, Hamid R. Amouzadeh, Jessica Choudhry, Guiandre Joseph

Social media sharing of information is becoming more important and is another metric with which to measure the reach of articles. The following 2019 articles from Drug Safety scored highly on the Altmetric system:

• Patient Registries: An Underused Resource for Medicines Evaluation: Operational proposals for increasing the use of patient registries in regulatory assessments Patricia McGettigan, Carla Alonso Olmo, Kelly Plueschke, Mireia Castillon, Daniel Nogueras Zondag, Priya Bahri, Xavier Kurz, Peter G. M. Mol

• Recommendations on the Use of Mobile Applications for the Collection and Communication of Pharmaceutical Product Safety Information: Lessons from IMI WEB-RADR Carrie E. Pierce, Sieta T. de Vries, Stephanie Bodin-Parssinen, Linda Härmark, Phil Tregunno, David J. Lewis, Simon Maskell, Raphael Van Eemeren, Alicia Ptaszynska-Neophytou, Victoria Newbould, Nabarun Dasgupta, Antoni F. Z. Wisniewski, Sara Gama, Peter G. M. Mol

• Establishing a Framework for the Use of Social Media in Pharmacovigilance in Europe Sabine Brosch, Anne-Marie de Ferran, Victoria Newbould, Diane Farkas, Marina Lengsavath, Phil Tregunno

• Use of a Patient-Friendly Terms List in the Adverse Drug Reaction Report Form: A Database Study Sieta T. de Vries, Judy Harrison, Patrick Revelle, Alicia Ptaszynska-Neophytou, Anna Radecka, Gowthamei Ragunathan, Phil Tregunno, Petra Denig, Peter G. M. Mol

• Prevalence and Nature of Medication Errors and Preventable Adverse Drug Events in Paediatric and Neonatal Intensive Care Settings: A Systematic Review Anwar A. Alghamdi, Richard N. Keers, Adam Sutherland, Darren M. Ashcroft

• Standardising the Classification of Harm Associated with Medication Errors: The Harm Associated with Medication Error Classification (HAMEC) Peter J. Gates, Melissa T. Baysari, Virginia Mumford, Magdalena Z. Raban, Johanna I. Westbrook

• Evaluating Renal Stress Using Pharmacokinetic Urinary Biomarker Data in Critically Ill Patients Receiving Vancomycin and/or Piperacillin–Tazobactam: A Secondary Analysis of the Multicenter Sapphire Study Sandra L. Kane-Gill, Marlies Ostermann, Jing Shi, Emily L. Joyce, John A. Kellum

• A Machine-Learning Algorithm to Optimise Automated Adverse Drug Reaction Detection from Clinical Coding Christopher McMaster, David Liew, Claire Keith, Parnaz Aminian, Albert Frauman

• Fluoroquinolone Use and the Risk of Collagen-Associated Adverse Events: A Systematic Review and Meta-Analysis Xinyu Yu, Ding-sheng Jiang, Jing Wang, Rui Wang, Taiqiang Chen, Kan Wang, Shiyi Cao, Xiang Wei

• Intravenous Infusion Administration: A Comparative Study of Practices and Errors Between the United States and England and Their Implications for Patient Safety Ann Blandford, Patricia C. Dykes, Bryony Dean Franklin, Dominic Furniss, Galal H. Galal-Edeen, Kumiko O. Schnock, David W. Bates

We thank the authors who have contributed articles to Drug Safety over the course of 2019. The skill and dedication of all authors are critical to the continued publication of the journal. The quality of published articles is also a testament to the significant efforts of the peer reviewers, whose commitment ensures that the journal’s content is held to the highest possible standard. We would like to thank the following individuals who acted as reviewers for Drug Safety in the last 12 months:

Eduardo C. Álvarez, Spain

Noha Abdel‐Wahab, USA

Ishag Adam, Sudan

Ade Adebajo, UK

Ismaïl Ahmed, France

Olalekan L. Aiyegbusi, UK

Thamir M. Alshammari, Saudi Arabia

Ippazio Antonazzo, Italy

Barbara Arone, USA

Keith J. August, USA

Haleh Bagheri, France

Priya Bahri, UK

Paolo Baldo, Italy

Robert Ball, USA

Juan M. Banda, USA

Doris Barcellona, Italy

Philip G. Bardin, Australia

Leonor Barile-Fabris, Mexico

Andrew Bate, UK

Francisco Batel-Marques, Portugal

Shannon Bates, Canada

Claudia Becker, Switzerland

Bernard Begaud, France

David S.H. Bell, USA

Delphine Bertram, The Netherlands

Sheila M. Bird, UK

Kjetil Bjornevik, Norway

Thomas J. Borody, Australia

Cedric Bousquet, France

Ian W. Boyd, Australia

Elliot G. Brown, Sweden

Zachary Burningham, USA

Katsiaryna Bykov, USA

Torbjörn Callréus, Denmark

Gianmario Candore, UK

Joseph Carreno, USA

Imti Choonara, UK

Fan Chung, UK

Arnon D. Cohen, Israel

Preciosa M. Coloma, The Netherlands

John Connolly, USA

Anthony R. Cox, UK

Giuseppe Curigliano, Italy

Paola M. Cutroneo, Italy

Gerald J. Dal Pan, USA

Olivia Dalleur, Belgium

Ghadeer Dawwas, USA

Fernando de Mora, Spain

Tobie J. de Villiers, South Africa

Luis Delgado, Portugal

Murthy Devarakonda, USA

Son Doan, USA

Glen Doherty, Ireland

Maria P. Dore, Italy

Antonios Douros, Canada

Kevin J. Downes, USA

Joseph P. Drozda, USA

Geneviève Durrieu, France

Steven Enoch, UK

Nazanin Falconer, Australia

Andreea Farcas, Romania

Claudia R. Felipe, Brazil

Martin Fernandez-Zapico, USA

Robin E. Ferner, UK

Kristian B. Filion, Canada

Daniel E. Furst, USA

Jose A. Garcia-Sanz, Spain

Sara Garfield, UK

Hans Garmo, UK

Peter Gates, Australia

Anthony Gerlach, USA

David Gerrett, UK

Thijs J. Giezen, The Netherlands

Alicia Gilsenan, USA

Rosa Gini, Italy

Michela Giustozzi, Italy

Thomas Goedecke, UK

Graciela Gonzalez, USA

Matthew Grainge, UK

Robin J. Green, South Africa

Luke E. Grzeskowiak, Australia

Linda Härmark, The Netherlands

Dan Halpern, USA

Felix Hammann, Switzerland

Lucinda A. Harris, USA

Manfred Hauben, USA

Sam Henry, USA

Alan M. Hochberg, Switzerland

Luc M.V. Hondeghem, Belgium

Keiko Hosohata, Japan

Ren-Jun Hsu, Taiwan, Republic of China

Yi-Shin Huang, Taiwan, Republic of China

Bruce P.J. Hugman, Thailand

Françoise Huguet, France

Shuen-Iu Hung, Taiwan, Republic of China

Lamar Hunt, USA

Noha Iessa, Switzerland

Pedro Inacio, Finland

Orit Itzhaki, Israel

Abhyuday Jagannatha, USA

Filip Janku, USA

Joseph A.M.J.L. Janssen, The Netherlands

Narumol Jarernsiripornkul, Thailand

Tord Juhlin, Sweden

Pramodini B. Kale-Pradhan, USA

Sandra L. Kane-Gill, USA

Bimal Kanish, India

Zain Kassam, USA

Shivani Kaushik, USA

Dimitrios N. Kiortsis, Greece

Ty H. Kiser, USA

Agnes V. Klein, Canada

Michael Klepper, USA

Bianca Kollhorst, Germany

Eleni Kotsampasakou, UK

David Kunkel, USA

Pekka Kurki, Finland

Adam La Caze, Australia

Timothy Y.Y. Lai, Hong Kong

Jean-Daniel Lalau, France

Maryse Lapeyre-Mestre, France

Mark G. Lebwohl, USA

Rannakoe Lehloenya, South Africa

Scott LeMaire, USA

Willem F. Lems, The Netherlands

Laura Leyva, Spain

Evangelos N. Liberopoulos, Greece

David Liew, Australia

Marianne Lisby, Denmark

Hongfang Liu, USA

Anja Mühlfeld, Germany

Lori MacCallum, Canada

Malcolm Maclure, Canada

Francois Maignen, UK

Marek Malik, UK

Edoardo Mannucci, Italy

Aukje K. Mantel-Teeuwisse, The Netherlands

Andrea Margulis, Spain

Judith C. Maro, USA

Aaron Masino, USA

Ilan Matok, Israel

Cristiano Matos, Spain

Faizan Mazhar, Italy

Deirdre McCarthy, USA

Lauren McCormack, USA

Mark J. McKeage, New Zealand

Ushma Mehta, South Africa

Joelle Micallef, France

Jae S. Min, USA

Philip B. Miner Jr, USA

Susan M. Mockus, USA

Daniel Morales, UK

Frank Moriarty, Ireland

Elaine H. Morrato, USA

Janne K. Mortensen, Denmark

Victoria Newbould, UK

Michael Nguyen, USA

Yoshihiro Noguchi, Japan

Shunsuke Ono, Japan

Vicki Osborne, UK

Barbara Osimani, Germany

Alexandra C. Pacurariu, The Netherlands

Manjunath P. Pai, USA

Nicolas Pallet, France

Josep Pane, USA

Anisha B. Patel, USA

Ana V. Pejčić, Serbia

Luigi A. Pini, Italy

Elisabetta Poluzzi, Italy

Nicole L. Pratt, Australia

Scott Proestel, USA

Livia Puljak, Croatia

Emanuel Raschi, Italy

Sawsan Rashdan, USA

Christel Renoux, Canada

Jenna M. Reps, UK

Lesley E. Rhodes, UK

Ryan Rodriguez, USA

Sirarat Sarntivijai, UK

Paul Sator, Austria

Stephen Schachterle, USA

Joep H.G. Scholl, The Netherlands

Susan Searles Nielsen, USA

John D. Seeger, USA

Jodi B. Segal, USA

Tavpritesh Sethi, India

Hong-cai Shang, Republic of China

Dhruv Sharma, USA

Afsaneh Shirani, USA

Sonal Singh, USA

Jim Slattery, UK

Meredith Y. Smith, USA

Rachel E. Sobel, USA

Julia Spoendlin, USA

Giovanni Stallone, Italy

Lampros Stergioulas, UK

Michael A. Stoto, USA

Dexter W. Sullivan, USA

Janet Sultana, Italy

Adam Sutherland, UK

Michael V. Tatley, New Zealand

Beverly Tchang, USA

Rolf Teschke, Germany

Ricky Turgeon, Canada

Paolo Usai-Satta, Italy

Florence van Hunsel, The Netherlands

Charlotte van Noord, The Netherlands

Bart Vanhaesebroeck, UK

Tiziana Vavalà, Italy

Mauro Venegoni, Italy

Katia Verhamme, The Netherlands

Priya Vijayvargiya, USA

Michail Vikelis, Greece

Mark Vincent, Canada

Erica Voss, USA

Izyan A. Wahab, Malaysia

Shirley Wang, USA

Raymond L. Woosley, USA

Susmitha Wunnava, USA

Kunihiro Yamaoka, Japan

Yi-Hsin Yang, Taiwan, Republic of China

Brad Yentzer, USA

Elad Yom-Tov, Israel

Dukyong Yoon, Republic of Korea

Hong Yu, USA

Qun-Ying Yue, Sweden

Rika Yuliwulandari, Indonesia

Pengyue Zhang, USA

Chrystia Zobniw, USA

In addition, we would like to thank the members of the journal’s Honorary Editorial Board, who have acted as peer reviewers and authors, and have provided guidance on journal content, policy and processes:

G. Caleb Alexander, USA

Laurent Azoulay, Canada

Bernard Bannwarth, France

Joanne Barnes, New Zealand

David W. Bates, USA

Frank M.C. Besag, UK

Nicholas Buckley, Australia

Ric O. Day, Australia

Fabrizio De Ponti, Italy

Alexander N.O. Dodoo, Ghana

I. Ralph Edwards, Sweden

Antonie C.G. Egberts, The Netherlands

Stephen J.W. Evans, UK

Adolfo Figueiras, Spain

Joshua Gagne, USA

Stephen A. Goldman, USA

Arnold J. Gordon, USA

Staffan Hägg, Sweden

Kenneth Y. Hartigan-Go, Philippines

Laurence Howes, Australia

David Hunt, UK

Susan Jick, USA

Vassilis Koutkias, Greece

Stephan Krähenbühl, Switzerland

Kiyoshi Kubota, Japan

Joan-Ramon Laporte, Spain

Deborah Layton, UK

Hervé Le Louet, France

James H. Lewis, USA

Marie Lindquist, Sweden

Yoon K. Loke, UK

Christopher R. Meier, Switzerland

Ronald Meijboom, The Netherlands

Peter G.M. Mol, The Netherlands

Jean-Louis Montastruc, France

Nichoals Moore, France

G. Niklas Norén, Sweden

Munir Pirmohamed, UK

Ruth L. Savage, New Zealand

Nigam Shah, USA

Rashmini R. Shah, UK

Saad Shakir, UK

Neil Shear, Canada

Olav Spigset, Norway

Nicholas P. Tatonetti, USA

Gianluca Trifirò, Italy

Marco Tuccori, Italy

Eugene P. van Puijenbroek, The Netherlands

Lynda V. Wilton, UK

Ian C.K. Wong, UK

Li Zhang, China

We do hope that you have found the articles published throughout the year in Drug Safety to be interesting and informative. The editorial schedule for 2020 is well under way, and we are looking forward to bringing you many high-quality and authoritative articles over the coming year.

With best wishes,

Nitin Joshi

Editor-in-Chief, Drug Safety